Elizabeth Yeu Lin, Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 13,953 shares at $85.00 ($1.2M) on 2026-09-04, disclosed to the SEC on 2026-09-09.
Scheduled sale ($1.2M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 1,590 | $135K | 11.1% |
| 2 | $85.00 | 5,387 | $458K | 37.5% |
| 3 | $90.00 | 1,590 | $143K | 11.7% |
| 4 | $90.00 | 5,386 | $485K | 39.7% |
| Total | $87.50 avg | 13,953 | $1.2M | 100% |
| Filing → |
| TARS | SELL | 2025-12-17 | $165K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |
| STAA | BUY | 2023-09-22 | $100K | — | Filing → |